AGT researchers net $4.4m NIH grant
Thursday, 03 July, 2003
Researchers associated with Victorian-based AGT Biosciences have landed a $AUD4.4 million grant from the US National Institutes of Health to fund its human gene discovery research.
The grant, awarded over a period of five years, will be shared between Prof Ahmed Kissebah of the Medical College of Wisconsin, Dr John Blangero of AGT and the Texas-based Southwest Foundation for Biomedical Research, and the AGT team at Deakin University, Geelong.
Prof Greg Collier, AGT's CEO and managing director, said in a statement that the grant was a strong affirmation of AGT's approach to solving problems of complex human diseases.
He said the grant would support a trilateral collaboration between Kissebah (population genetics), Blangero's team (statistical genomics) and AGT's eXpress technology platform.
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
